Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8

Yan, W, Liu, S, Xu, E, Zhang, J, Zhang, Y, Chen, X, Chen, X·2013·Oncogene
DOI 10.1038/onc.2012.81

Cited by (156)

Items 101–156 of 156

  1. Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression
    Julie Xia Zhou, Ewud Agborbesong, Xiaoyan Li, Xiaogang Li · 2022 · International Journal of Molecular Sciences
  2. P53 together with ferroptosis: a promising strategy leaving cancer cells without escape
    Jianhao Zhan, Jisheng Wang, Yuqing Liang, Xiaoping Zeng, Enliang Li, Hongmei Wang · 2023 · Acta Biochimica et Biophysica Sinica
  3. HOXA5 Expression Is Elevated in Breast Cancer and Is Transcriptionally Regulated by Estradiol
    Imran Hussain, Paromita Deb, Avisankar Chini, Monira Obaid, Arunoday Bhan, Khairul I. Ansari, Bibhu Prasad Mishra, Samara A.M. Bobzean, S. M. Nashir Udden, Prasanna G. Alluri et al. · 2020 · Frontiers in Genetics
  4. Modelling drug-induced cellular perturbation responses with a biologically informed dual-branch transformer
    Yue Guo, Hao Zhang, Haitao Hu, Jialu Wu, Ji Cao, Chang‐Yu Hsieh, Bo Yang · 2026 · Nature Machine Intelligence
  5. TP53in adult acute lymphoblastic leukemia
    Silvia Salmoiraghi, Alessandro Rambaldi, Orietta Spinelli · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
  6. TAp73 Protein Stability Is Controlled by Histone Deacetylase 1 via Regulation of Hsp90 Chaperone Function
    Jin Zhang, Enshun Xu, Xinbin Chen · 2013 · Journal of Biological Chemistry
  7. Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and scope of an isoindolin-2-yl linker with an α-amino amide as the zinc-binding unit
    Simon O. R. Greenwood, A. W. Edith Chan, D. Flemming Hansen, Charles M. Marson · 2020 · Bioorganic & Medicinal Chemistry Letters
  8. The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
    Ying Cai, Wenli Cui, Weixiang Chen, Ping Wei, Yayun Chi, Ping Zhang, Rui Bi, Xiaoyan Zhou · 2013 · Cancer Cell International
  9. Exploring the binding mechanism of HDAC8 selective inhibitors: Lessons from the modification of Cap group
    Min Zhang, Jun Biao Ying, Song Wang, Dian He, Hongtian Zhu, Chenghong Zhang, Lei Tang, Ruili Lin, Yang Zhang · 2020 · Journal of Cellular Biochemistry
  10. The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration
    Sonja Mertsch, Oliver Holger Krämer · 2017 · Cytokine & Growth Factor Reviews
  11. Nb-induced stabilisation of p53 in HPV-infected cells
    Anneleen Steels, Laura Vannevel, Olivier Zwaenepoel, Jan Gettemans · 2019 · Scientific Reports
  12. Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells
    Concepción Fernández‐Rodríguez, Antonio Salar, Alfons Navarro, Eva Gimeno, Silvia Pairet, Laura Camacho, Mariana Paola Ferraro, Sergi Serrano, Carlos Besses, Beatríz Bellosillo et al. · 2015 · Leukemia & lymphoma/Leukemia and lymphoma
  13. Efficacy of an online intervention to reduce alcohol-related risks among community college students
    Elizabeth Donovan, Pronabesh Das Mahapatra, Traci Craig Green, Emil J. Chiauzzi, Kimberly McHugh, Amanda Hemm · 2015 · Addiction Research & Theory
  14. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation
    Darren M. Hutt, Daniela Roth, Christelle Marchal, Marion Bouchecareilh · 2016 · Methods in molecular biology
  15. Prediction of Epithelial Ovarian Cancer Outcomes With Integration of Genomic Data
    Andreea Mihai Newtson, Eric Jeffrey Devor, Jesús González Bosquet · 2019 · Clinical Obstetrics & Gynecology
  16. Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
    Megan E. McDonald, Erin A Salinas, Eric Jeffrey Devor, Andreea Mihai Newtson, Kristina W. Thiel, Michael Joseph Goodheart, David Bender, Brian J. Smith, Kimberly Kay Leslie, Jesús González Bosquet · 2019 · International Journal of Molecular Sciences
  17. Cooperation of p53 Mutations with Other Oncogenic Alterations in Cancer
    Javier E. Girardini, Dawid Walerych, Giannino Del Sal · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
  18. Gain-of-function hot spot mutant p53R248Q regulation of integrin/FAK/ERK signaling in esophageal squamous cell carcinoma
    Valen Zhuoyou Yu, Shan Shan So, Maria Li Lung · 2020 · Translational Oncology
  19. Effect of sodium butyrate on HDAC8 mRNA expression in colorectal cancer cell lines and molecular docking study of LHX1 - sodium butyrate interaction
    Flora Forouzesh, Mahsa Ghiaghi, Hamzeh Rahimi · 2020 · EXCLI journal
  20. Modeling the Etiology of p53-mutated Cancer Cells
    Ricardo E. Perez, Hong Shen, Lei Duan, Reuben H. Kim, Terresa Kim, No-Hee Park, Carl G. Maki · 2016 · Journal of Biological Chemistry
  21. Efficacy of convection enhanced delivery of MTX110 (soluble panobinostat) in preclinical Diffuse Intrinsic Pontine Glioma models using metabolic hyperpolarized 13C imaging
    Justyna Magdalena Przystal, Ilwoo Park, Jie Zhang, Piotr Hadaczek, Krystof S. Bankiewicz, Nalin M. Gupta, Javad Nazarian, Sabine Mueller · 2023 · EJC Paediatric Oncology
  22. Detection and Quantification of Tp53 and p53-Anti-p53 Autoantibody Immune Complex: Promising Biomarkers in Early Stage Lung Cancer Diagnosis
    Keum‐Soo Song, Satish Balasaheb Nimse, Shrikant Dashrath Warkad, Junghoon Kim, Heyjin Kim, Taisun Kim · 2022 · Biosensors
  23. Investigating the synergistic potential of TRAIL and SAHA in inducing apoptosis in MOLT-4 cancer cells
    Masoud Mohammad Mirzapour, Majid Farshdousti Hagh, Faroogh Marofi, Saeed Solali, Arsalan Alaei · 2023 · Biochemical and Biophysical Research Communications
  24. Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes
    Priyanka Ray, Abbas Sedigh, Matthew I. Confeld, Lina Alhalhooly, Kweeni Iduoku, Gerardo M. Casañola‐Martín, Hai Pham‐The, Bakhtiyor Rasulev, Yongki Choi, Zhongyu Yang et al. · 2024 · Journal of Materials Chemistry B
  25. Epigenetic-based cancer therapeutics: new potential HDAC8 inhibitors
    Malihe Hassanzadeh, Shabnam Mahernia, Gianluca Caprini, Gianluca Fossati, Mehdi Adib, Faezeh Moakedi, Massoud Amanlou · 2020 · Journal of Biomolecular Structure and Dynamics
  26. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression
    Danyan Chen, Zhaonan Shen, Xi Cheng, Qi Wang, Junlin Zhou, Fang Ren, Yue Sun, Hongman Wang, Rongxi Huang · 2021 · Bioengineered
  27. Molecular and immune targets for Merkel cell carcinoma therapy and prevention
    Leah Cohen, Kenneth Yee Tsai · 2019 · Molecular Carcinogenesis
  28. Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review
    Irina Lyakhova, Mariia A. Piatkova, Valeriia S. Gulaia, Alexander O. Romanishin, Mikhail E. Shmelev, Andrey S. Bryukhovetskiy, Aruna Sharma, Hari Shanker Sharma, Rodion Khotimchenko, Igor Bryukhovetskiy · 2020 · International review of neurobiology
  29. Mechanistic Underpinnings of Epigenetic Enzyme-Responsive Nanoparticles
    Raj Shankar Hazra, Debasmita Dutta, Md Rakib Hasan Khan, Sakurako Tani, Chowdhury S. Abdullah, Naznin Sultana Remex, Richa Aishwarya, Tamjid Islam, Zhongyu Yang, Sanku Mallik et al. · 2025 · ACS Applied Bio Materials
  30. Cell Signaling Model Connects Vorinostat Pharmacokinetics and Tumor Growth Response in Multiple Myeloma Xenografts
    Charvi Nanavati, Donna M. Ruszaj, Donald E. Mager · 2017 · CPT Pharmacometrics & Systems Pharmacology
  31. The combination of histone deacetylase and p53 expressions and histological subtype has prognostic implication in uterine leiomyosarcoma
    Min‐Hyun Baek, Jeong‐Yeol Park, Yangsoon Park, Kyu-Rae Kim, Dae‐Yeon Kim, Dae‐Shik Suh, Jong-Hyeok Kim, Yong‐Man Kim, Young‐Tak Kim, Joo‐Hyun Nam · 2019 · Japanese Journal of Clinical Oncology
  32. Tumor Dormancy, Quiescence, and Senescence, Volume 1
    M. A. Hayat · 2013 · Springer eBooks
  33. Network-Based Systems Analysis Explains Sequence-Dependent Synergism of Bortezomib and Vorinostat in Multiple Myeloma
    Charvi Nanavati, Donald E. Mager · 2021 · The AAPS Journal
  34. Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas
    Zachary Braunstein, Miguel Ruiz, Walter G. Hanel, Polina Shindiapina, John C. Reneau, Jonathan Edward Brammer · 2022 · Journal of Personalized Medicine
  35. Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator
    Mohammed Mukhtar Yusif · 2022 · European Journal of Medicinal Chemistry Reports
  36. The Potential Role of HDAC1 and HDAC3 Immunoexpression in P53 Downregulation and Tumor Aggressiveness of Colon and Rectum Carcinomas Patients
    Yasir Basim Qaddoori, Ahmed S. Al-Khafaji, Basim Mohammed Khashman, Kifah Hamdan AbdulGhafour · 2025 · Experimental Oncology
  37. Targeting TP53 to augment therapeutic response in head and neck cancer
    Abdullah A. Osman, Antje Lindemann, Li Wang, Steven Jay Frank, Jeffrey N. Myers · 2020 · Elsevier eBooks
  38. Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers
    Shaoli Das, Xiang Deng, Kevin A. Camphausen, Uma T. Shankavaram · 2020 · Archives of Cancer Biology and Therapy
  39. Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the nucleoporins and nuclear envelope in cervical cancer
    Harsha Rani, Shabir Ahmad Ganai, Vijayalakshmi Mahadevan · 2025 · Translational Oncology
  40. Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment
    Jiranan Chotitumnavee, Peeratchai Seemaung, Rapeewan Settacomkul, Ratchanon Sukprasert, Yukihiro Itoh, Takayoshi Suzuki, Sirada Srihirun, Christopher Power, Pornpun Vivithanaporn · 2026 · Drug Design Development and Therapy
  41. In silico analysis prediction of HepTH1-5 as a potential therapeutic agent by targeting tumour suppressor protein networks
    Wan-Atirah Azemin, Nadiawati Alias, Abdul Manaf Ali, Mohd Shahir Shamsir · 2021 · Journal of Biomolecular Structure and Dynamics
  42. HDAC8-mediated inhibition of EP300 drives a neural crest-like transcriptional state that increases melanoma brain metastasis
    Michael F. Emmons, Richard Lynn Bennett, Alberto Riva, Chao Zhang, Robert J.B. Macaulay, Daphné Dupéré-Richer, Bin Fang, Edward Seto, John M. Koomen, Jiannong Li et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Histone Deacetylase Inhibitor Induces Replicative Senescence of Mesenchymal Stem Cells
    Seunghee Lee, Ji‐Won Jung, Kyung‐Sun Kang · 2013 · Springer eBooks
  44. Mutational analysis of non-coding genome in prostate cancer using whole genome sequencing
    Sanamjeet Virdi · 2014 · Tampere University Institutional Repository (Tampere University)
  45. Characterization and functional analysis of mutant p53 secretome in human cancer
    Reshma Shakya · 2016 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  46. The effect of matrix stiffness, composition, and three-dimensionality on p53 expression in engineered human bone tumors
    Zen Liu · 2017 · Columbia Academic Commons (Columbia University)
  47. Target Identification of HDAC8 Isoform for the Treatment of Cancer
    A. Umamaheswari, Ayarivan Puratchikody, Sakthivel Balasubramaniyan · 2018 · Advances in medical technologies and clinical practice book series
  48. P53 and anti‐p53 autoantibody complex versus anti‐p53 antibody as a biomarker for gastrointestinal cancer
    Vahideh Hamidi, Arefeh Ebrahimian Shiadeh, Alijan Tabarraei, Hadi Razavi Nikoo, Farzin Sadeghi, Gh. Kamrani, Yousef Yahyapour, Abdolvahab Moradi · 2025 · Precision Medical Sciences
  49. TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches
    Shweta Deshpande, Wing Fai Li, Junmin Song, Mark Forsberg, Claudio Cerchione, Giovanni Martinelli, Marina Y Konopleva · 2026 · Frontiers in Oncology
  50. Discovery of 6-substituted indole and tetrahydroquinoline derivatives as selective HDAC8 inhibitors
    Wen Jun Li, Ruixue Cheng, Yingjie Chang, Xue Li, Zhongcheng Zhao, Jiaqi Liu, Yan Zhang, Shengda Cao, Xuben Hou, Hao Fang · 2026 · Bioorganic & Medicinal Chemistry
  51. INVESTIGATION OF THE INHIBITION MECHANISM OF SOME HDAC8 INHIBITORS THROUGH COMPUTATIONAL METHODS
    Muhammed Tılahun Muhammed, İrem Sarı, Sude Nur Şahan · 2026 · Ankara Universitesi Eczacilik Fakultesi Dergisi
  52. DNA Polymerase Eta Stabilizes Mutant p53 Protein to Increase Tumor Cell Growth
    Jin Zhang, Yang Shi, Xinbin Chen · 2026 · Cells
  53. BindingDB Entry 50022755: HDAC8 as a target in drug discovery: Function, structure and design.
    BindingDB · 2026 · UC San Diego
  54. BindingDB Entry 50002428: Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.
    BindingDB · 2020 · UC San Diego
  55. BindingDB Entry 50010688: Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and scope of an isoindolin-2-yl linker with an α-amino amide as the zinc-binding unit.
    BindingDB · 2021 · UC San Diego
  56. BindingDB Entry 50010426: Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview.
    BindingDB · 2021 · UC San Diego